Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,066	4,506	3,499	2,040	1,742	1,182
Market Cap Growth	83.40%	28.76%	71.56%	17.08%	47.34%	23.36%
Enterprise Value	7,246	3,819	2,909	1,642	1,388	899
Last Close Price	272.91	156.66	124.06	79.22	69.95	60.00
PE Ratio	41.75	50.54	320.10	-	-	-
Forward PE	39.76	33.31	-	-	-	-
PS Ratio	21.11	15.51	69.02	-	-	-
PB Ratio	6.95	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	7.12	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	48.92	37.81	-	-	-	-
P/OCF Ratio	45.97	36.51	-	-	-	-
EV/Sales Ratio	19.42	13.15	57.38	-	-	-
EV/EBITDA Ratio	45.38	36.14	-	-	-	-
EV/EBIT Ratio	45.76	37.01	-	-	-	-
EV/FCF Ratio	43.76	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.34	0.31	0.07	-	-	-
Inventory Turnover	0.76	1.20	-	-	-	-
Quick Ratio	9.43	6.89	17.35	13.14	17.02	17.56
Current Ratio	10.14	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	19.66%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	8.91%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Invested Capital (ROIC)	40.36%	31.60%	-40.54%	-76.89%	-74.23%	-177.13%
Return on Capital Employed (ROCE)	13.80%	10.80%	-12.40%	-22.90%	-11.60%	-11.20%
Earnings Yield	2.46%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.04%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-1.34%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q